Cannabis Law Report

SEPTEMBER 1, 2021

In countries where medical cannabis is legal, patients have more treatment options to choose from. Patients in the UK who are suffering from epilepsy, multiple sclerosis, insomnia, chronic pain, anxiety, and other medical conditions can use medical cannabis as an adjunct or alternative treatment.

Legalization 109

Legalization Marijuana Treatment Patients 109

MMJ Recs

APRIL 5, 2022

Seed banks have opened across the state and many Missouri MMJ patients are taking the opportunity to grow their own private supply of high-quality medical marijuana. A maximum of two license-holders can grow their marijuana in one location (these people can be two patients, a patient and a caregiver, or two caregivers).

Cultivation 52

Cultivation Banking Treatment Chronic Pain 52

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Theodore happens to also be an addiction expert who refuses to provide treatment to patients that choose to consume cannabis as he believes it interferes with the treatment of other addictions.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Puff Puff Post

MARCH 2, 2020

. · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp. Web Site: [link].

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Cannabis Law Report

AUGUST 21, 2019

The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Puff Puff Post

MARCH 2, 2020

. · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp. Web Site: [link].

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

NOVEMBER 10, 2021

Cannabidiol (CBD) oil has grown in popularity over the years, with the media considering it as an add-in booster. Additionally, when a diabetes drug interferes with CBD, it may cause diarrhea in a patient. But, CBD may be an option for managing chronic pain, insomnia, and anxiety with the proper doses. Bottom Line.

Oil 52

Oil CBD Research and Development Chronic Pain 52

Kind Meds (Cannabis Education Blog)

JUNE 27, 2021

Cannabis cigarettes were even advertised in popular media at the time. Towards the latter part of the 1800s, cannabis was an ingredient used by the pharmaceutical industry in common medications to help treat ailments such as pain and nausea relief. Nerve pain. Epilepsy and seizures. Muscle relaxer. Anxiety reducer.

Pharmaceutical 99

Pharmaceutical Chronic Pain Medicine Nerve Pain 99

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. Source: The Guardian ). Source: SIPSE.COM ).

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Veriheal

OCTOBER 1, 2020

America: Lee Carrol Broker was sentenced to life in prison without the possibility of parole on the groups that he grew three dozen cannabis plants intended for personal use since he suffered from chronic pain as a result of being 75 years old and a disabled veteran. . The UK’s 2018 Medicinal Cannabis Regulations.

Legalization 104

Legalization Oil Medicine Media 104

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. This article analyses media representations of medicinal cannabis in Australian medical publications. Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., Media: Laura Radocaj. BERWYN, Pa.–(BUSINESS

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

NOVEMBER 10, 2021

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. Media: Laura Radocaj. In October 2021, Virpax announced that a $1.87 Forward-Looking Statement.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

CannaTech

MARCH 29, 2019

Last year, after much lobbying by and on behalf of Alfie Dingle and Billie Caldwell (The British Charlotte Figi), on November 1, 2018, specialist doctors were approved to prescribe various forms of marijuana for patients suffering from a range of ailments. The UK is the World’s Largest Cannabis Exporter. Only specialist (sic.

Chronic Pain 50

Chronic Pain Access Patients Food 50

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Cannabis Law Report

MARCH 6, 2020

KLS-13019 has not been reviewed or approved for patient use by the U.S. The Company’s KLS Family of proprietary molecules focuses on treating oxidative stress-related diseases such as HE, chronic pain from neuropathies like CIPN, and neurodegenerative diseases like CTE. CMW Media. About Kannalife, Inc. 858-264-6600.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

Cannabis Law Report

SEPTEMBER 10, 2019

Instead, CBD is fast garnering a reputation in the medical world as a potentially soothing treatment for conditions like arthritis, epilepsy , mental stress, or muscle pain, even as for certain forms of cancer.). They are to relieve chemotherapy-induced nausea and vomiting, epilepsy, multiple sclerosis, and chronic pain.

CBD 45

CBD Wellness and Beauty Banking Epilepsy 45

Cannabis Law Report

DECEMBER 28, 2021

We added VRP324 which is an intranasally delivered cannabidiol (‘CBD’) formulation for the management of epilepsy in adults and children. Virpax anticipates enrollment of the first patient by early second quarter of 2022. to conduct this study in Canada.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

SEPTEMBER 1, 2022

AUSTIN, Texas, August 31, 2022 –( BUSINESS WIRE )–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). of cannabis patients. It’s not a maybe. It’s a certainty. An additional 45.9%

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

AUGUST 31, 2022

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). Chronic pain is one of the most prevalent and provable conditions that medical cannabis can positively impact.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

StrainConnect

FEBRUARY 8, 2019

From cancer(11) to epilepsy(12), there seems to be very little that cannabis cannot help with. Now, remember that everyone is different, and new patients will likely still “get high” from products that combine both THC and CBD. Endocannabinoids and epilepsy - Science Direct. Myth #3: You can overdose on cannabinoids.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Veriheal

MAY 24, 2023

Reduction in religious affiliation, a drop in punitiveness, and a shift in media framing may have all contributed to changing attitudes. This leaves millions of medical cannabis patients unable to consume their legal marijuana doses until they get home. even in recreational marijuana states.

Consumption 84

Consumption Vaping Chronic Pain Recreational 84